Peripheral arterial disease of extremities – guidelines for diagnostic and treatment

Česká verzia

Authors: V. Štvrtinová ¹; V. Šefránek ²; J. Murín ³; A. Dukát ⁴; J. Tomka ²; I. Vulev ⁵; O. Bzdúchová ¹; A. Džupina ¹; J. Bilický ⁵
Authors place of work: Slovenská angiologická spoločnosť Slovenskej lekárskej spoločnosti, predsedkyňa prof. MUDr. Viera Štvrtinová, CSc. ¹; Slovenská spoločnosť pre cievnu chirurgiu Slovenskej lekárskej spoločnosti, predseda prof. MUDr. Vladimír Šefránek, CSc. ²; Slovenská kardiologická spoločnosť Slovenskej lekárskej spoločnosti, predseda prof. MUDr. Ján Murín, CSc. ³; Slovenská internistická spoločnosť Slovenskej lekárskej spoločnosti, predseda prof. MUDr. Andrej Dukát, CSc. ⁴; Slovenská radiologická spoločnosť Slovenskej lekárskej spoločnosti, predseda prof. MUDr. Jozef Bilický, CSc. ⁵
Published in the journal: Vnitř Lék 2008; 54(2): 195-202
Category: Guidelines

Summary

Diagnostic and therapeutic guidelines of peripheral arterial disease of extremities recommanded by five scientific societies of Slovak Medical Association (Slovak Angiological Society, Slovak Society for Vascular Surgery, Slovak Cardiologic Society, Slovak Internal Society and Slovak Radiologic Society) are discussed in this article. Peripheral arterial disease (PAO) of extremities is an important manifestation of systemic atherosclerosis The lower the ankle-brachial pressure index, the greater the risk of serious cardiovascular events (e.g. myocardial infarction, stroke). Nevertheless, patients with PAO are undertreated with regard to use of antiplatelet drugs or lipid-lowering drugs, as compared with patients with coronary artery disease.

Key words:
peripheral arterial disease of extremities - diagnosis - treatment

Zdroje

1. CAPRIE steering committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996; 348: 1329-1339.

2. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women < 62 years of age. Am J Cardiol 1994; 74: 64-65.

3. Heidrich H, Wenk R, Hesse P. Frequency of asymptomatic peripheral arterial disease in patients entering the department of general and internal medicine of a general-care hospital. Vasa 2004; 33: 63-67.

4. Diehm C, Schuster A, Allenberg JR et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105.

5. European Working Group on Critical Limb Ischemia, Second European Consensus on Chronic Critical Limb Ischemia. Circulation 1991; 84 (Suppl IV): 1-26.

6. Nogren L. Critical limb ischaemia: an overview. Critical ischemia 1998; 7: 89-94.

7. TASC - Management of Peripheral Arterial Disease (PAD). TransAtlantic Inter-Society Consenzus (TASC). Int Angiol 2000; 19 (Suppl 1): 1-310.

8. Puchmayer V, Roztočil K. Praktická angiologie. 2. rozšírené a přepracované vydání. Praha: Triton 2007.

9. Staněk F. Ischemická choroba dolních končetin (ICHDK) - chronické formy. In: Karetová D, Staněk F (Eds). Angiologie pro praxi. Praha: Maxdorf 2001, 21-75.

10. Ray SA, Srodon PD, Taylor RS et al. Reliability of ankle-brachial index measurement by junior doctors. Br J Surg 1994; 81: 181-190.

11. Rutherford RB, Baker JD, Ernst C et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26: 517-538.

12. Heidrich H, Wenk R, Hesse P. Frequency of asymptomatic peripheral arterial disease in patients entering the department of general and internal medicine of a general-care hospital. Vasa 2004; 33: 63-67.

13. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-1620.

14. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Guidelines for Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary. JACC 2006; 47: 1239-1312.

15. Orchard TJ, Strandness DE. Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992, New Orleans, Louisiana. Circulation 1993; 88: 819-828.

16. Cachovan M. Ergometrie. In: Alexander K (Ed). Gefässkrankenheiten. Urban a Schwarzenberg: München - Wien - Baltimore 1994, 142-144.

17. Andreozzi GM, Arosio E, Martini R. Consensus on Intermittent Claudication, ABANO Terme, Italy, 2005 CEVF-CI.

18. Federman DG, Bravata DM, Kirsner RS. Peripheral arterial disease. A systemic disease extending beyond the affected extremity. Geriatrics 2004; 59: 29-39.

19. Hackam DG, Goodman SG, Anand SS. Management of risk in peripheral artery disease: recent therapeutic advances. Am Heart J 2005; 150: 35-40.

20. Abramson BL, Huckell V, Anand S et al. Canadian Cardiovascular Society Consensus Conference: Peripheral arterial disease - Executive summary. Can J Cardiol 2005; 21: 997-1006.

21. Bounameaux H, Wutschert R. Drug treatment strategies for peripheral obliterative arteriopathy. Drugs 1998; 56(Suppl 3): 17-23.

22. Hiatt WR. The US experience with cilostazol in treating intermittent claudication. Atherosclerosis 2005 (dostupné na www.elsevier.com/locate/atherosclerosis).

23. Štvrtinová V, Ambrózy E, Kriška M. Lieky pri poruchách periférnej cirkulácie. In: Kriška M (Ed). Memorix klinickej farmakológie. Bratislava: SAP 2006: 257-262.

24. Rupprecht HJ, Darius H, Borkowski U et al. Comparison of antiplatelet effects of aspirin, ticlopidine or their combination after stent implantation. Circulation 1998; 97: 1046-1052.

25. Makkar RR, Eigler NL, Kaul S. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo modelof high-shear induced stent thrombosis. Eur Heart J 1998; 19: 1538-1546.

26. Urban P, Macaya C, Rupprecht HJ et al. Randomised evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patient: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998; 98: 2126-2132.

27. Štvrtinová V, Šefránek V, Murín J et al. Odporúčania pre diagnostiku a liečbu periférneho artériového ochorenia končatín. Odporúčania Slovenskej angiologickej spoločnosti, Slovenskej spoločnosti pre cievnu chirurgiu, Slovenskej kardiologickej spoločnosti, Slovenskej internistickej spoločnosti a Slovenskej rádiologickej spoločnosti.. Kardiológia 2006; 6: 317-326.